Functional Outcomes Following Limb Sparing Surgery for Sarcoma Patients
1 other identifier
observational
N/A
1 country
1
Brief Summary
Primary Objectives:
- 1.To classify the types of wound healing complications that occur after pre-operative radiation therapy and limb sparing resection for the treatment of soft tissue sarcomas of the extremity.
- 2.To evaluate the impact of each complication type on patient function and quality of life using the Toronto Extremity Salvage Score (TESS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 26, 2007
CompletedFirst Posted
Study publicly available on registry
July 27, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2007
CompletedAugust 1, 2012
July 1, 2012
1.1 years
July 26, 2007
July 31, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Endpoints for this study will be anatomic site, histological subtype, primary wound closure, wound complication type, need for secondary operation and type of secondary operation.
1 Year
Study Arms (1)
1
Patients with a diagnosis of soft tissue sarcoma.
Interventions
Eligibility Criteria
Patients with a diagnosis of soft tissue sarcoma.
You may qualify if:
- Diagnosis of soft tissue sarcoma with histopathologic confirmation.
- Treatment protocol that includes pre-operative radiation therapy.
- Treatment protocol that includes limb-sparing surgical resection.
- Patient has received MD Anderson Cancer Center multidisciplinary care.
- Patient must be at least three years post-operative.
You may not qualify if:
- Previous radiotherapy to the local site.
- Presence of regional or distant metastases.
- Major medical co-morbidities (eg. cerebrovascular accident, congestive heart failure, concurrent malignancy) or disabilities unrelated to treatment for soft tissue sarcoma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
U.T.M.D. Anderson Cancer Center
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles E. Butler, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2007
First Posted
July 27, 2007
Study Start
September 1, 2006
Primary Completion
October 1, 2007
Study Completion
October 1, 2007
Last Updated
August 1, 2012
Record last verified: 2012-07